Apigenin and hesperidin augment the toxic effect of doxorubicin against HepG2 cells.
Agnieszka KorgaMarta OstrowskaAleksandra JozefczykMagdalena IwanRafal WojcikGrazyna ZgorkaMariola HerbetGemma Gomez VilarrublaJaroslaw DudkaPublished in: BMC pharmacology & toxicology (2019)
The obtained results indicate the existence of a very effective cytotoxic mechanism in the HepG2 cells of the combined effect of doxorubicin and apigenin (or hesperidin), not related to the oxidative stress. To explain this synergy mechanism, further research is needed, The observed intensification of the cytotoxic effect of doxorubicin by this flavonoids may be a promising direction of the research on the therapy of hepatocellular carcinoma, especially in a chemoembolization.